A recent study observed a large number of CD8+ T cells in the exocrine glands of SS animal models and patients; removal of these resident CD8+ T cells after disease onset can alleviate the pathology [47], which may form the basis of future SS treatments. This evidence concerns the gene CD8A and synovial sarcoma.